文献速递造血干细胞移植与细胞治疗

基因修饰间充质干细胞外泌体的免疫调节功能

[The immunoregulatory functions of exosome derived from mesenchymal stem cells that are genetically modified by adeno-associated virus].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2021-01-01

该研究在小鼠急性GVHD模型中验证了间充质干细胞来源外泌体(MSC-exosome)与MSC相似的免疫调节作用,并利用AAV2YF3突变体建立定向修饰MSC-exosome的方法。经PD-L1或PD-L1-ITGB1修饰的外泌体可更有效抑制活化T细胞增殖并提高Treg比例。

要点

  • MSC-exosome(300 μg×3次)可改善急性GVHD小鼠体重减低。
  • 人MSC-exosome在体外抑制活化T细胞增殖。
  • PD-L1或PD-L1-ITGB1修饰增强外泌体免疫抑制功能。

核心结论

  • MSC-exosome具有与MSC相似的免疫调节作用。
  • 经PD-L1和PD-L1-ITGB1修饰的MSC-exosome能有效抑制活化T细胞增殖并诱导提高Treg比例。

研究设计与样本

  • 构建小鼠急性GVHD模型,比较不同剂量MSC-exosome组与MSC组的生理指标评分、生存和体重减低程度。
  • 通过体外T细胞活化实验和体内OVA抗原特异性T细胞活化实验检测活化T细胞增殖水平。
  • 构建携带PD-L1和PD-L1-ITGB1的AAV2YF3突变体感染人MSC,分离外泌体并检测其功能。

主要发现

  • MSC-exosome(300 μg×3次)和小鼠MSC(1×10^6×3次)均有效改善急性GVHD小鼠的生理指标评分、生存和体重减低程度。
  • 相比IL-2对照组,10、25、50 μg人MSC-exosome和1×10^6人MSC体外共孵育抑制活化T细胞增殖,增殖比例分别为86.0%(IL-2)、40.0%、39.6%、42.8%和41.0%。
  • 相比PBS对照组,50、100、200 μg小鼠MSC-exosome和1×10^6小鼠MSC体内抑制抗原特异性活化OT-1细胞增殖,增殖比例分别为42.6%、33.1%、14.2%、10.6%和14.6%。
  • 携带PD-L1和PD-L1-ITGB1的AAV2YF3突变体定向修饰人MSC-exosome的表达率分别超过40%和60%。
  • 相比天然状态,PD-L1和PD-L1-ITGB1定向修饰后MSC-exosome在体内对OT-1细胞具有更好的增殖抑制效果,体外明显抑制活化T细胞增殖并诱导提高Treg比例。

临床怎么用

  • MSC-exosome可能作为急性GVHD的候选免疫调节策略。
  • PD-L1或PD-L1-ITGB1基因修饰可增强MSC-exosome的免疫抑制功能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objectives: To verify the effects and mechanisms of natural MSC-exosome in treating acute GVHD in mice, explore and establish a method for targeted modification of MSC-exosome, and verify the functions of the modified MSC-exosome. Methods: In different doses of MSC-exosome groups and MSC group, weight loss in acute GVHD mice was observed; then the proliferation levels of activated T cells were measured through T cell activation experiment in vitro and OVA antigen-specific T cell activation experiment in vivo. AAV2YF3 mutants carrying PD-L1 and PD-L1-ITGB1 were obtained after the construction of recombinant expression vectors and were then applied to infect human MSC to modify their exosome. The immunoregulatory functions of the modified MSC-exosome were measured with the abovementioned methods. Results: ①Mouse MSC-exosome (300 μg×3 times) and MSC (1×10(6)×3 times) effectively alleviated the weight loss in acute GVHD mice. ②Compared with IL-2, 10, 25 and 50 μg human MSC-exosome inhibited the proliferation of activated T cells in vitro, respectively, 86.0% (IL-2) , 40.0%, 39.6%, and 42.8%; compared with PBS, 50, 100 and 200 μg mouse MSC-exosome inhibited the proliferation of antigen-specific activated OT-1 cells in vivo, respectively, 42.6%, 33.1%, 14.2%, and 10.6%. ③After the infection of AAV2YF3 mutant carrying PD-L1 or PD-L1-ITGB1, the positive proportion of MSC-exosome exceeds 40% and 60%, respectively. ④Compared with the natural state, MSC-exosome modified by PD-L1 or PD-L1-ITGB1 showed better proliferation inhibitory effect in vivo and increased the proportion of Treg cells in vitro. Conclusions: MSC-exosome exhibited similar immunomodulatory effects with MSC. MSC-exosome after PD-L1 and PD-L1-ITGB1-targeted modification effectively inhibited the proliferation of activated T cells and increased the proportion of Treg cells. 目的: 验证天然状态间充质干细胞来源的外泌体(MSC-exosome)治疗小鼠急性移植物抗宿主病(GVHD)的效果和可能机制,探索并建立定向基因修饰MSC-exosome的方法并验证修饰后MSC-exosome的功能。 方法: 构建小鼠急性GVHD模型,观察比较不同剂量MSC-exosome组和MSC组的生理指标评分、生存和体重减低程度;进而通过体外T细胞活化实验和体内OVA抗原特异性T细胞活化实验检测比较组间活化T细胞的增殖水平。构建重组表达载体,获得携带PD-L1和PD-L1-ITGB1的AAV2YF3突变体,进而感染人MSC,分离获得其外泌体。检测比较天然状态和修饰后MSC-exosome在体外和体内对活化T细胞的增殖水平和调节性T细胞(Treg)比例的影响。 结果: ①MSC-exosome(300 μg×3次)和小鼠MSC(1×10(6)×3次)均能够有效改善急性GVHD小鼠的生理指标评分、生存和体重减低程度。②相比IL-2对照组,10、25、50 μg人MSC-exosome和1×10(6)人MSC体外共孵育处理均能够抑制活化T细胞的增殖,增殖比例分别为86.0%(IL-2)、40.0%、39.6%、42.8%和41.0%;相比PBS对照组,50、100、200 μg小鼠MSC-exosome和1×10(6)小鼠MSC在体内均能够抑制抗原特异性活化的OT-1细胞的增殖,增殖比例分别为42.6%、33.1%、14.2%、10.6%和14.6%。③携带PD-L1和PD-L1-ITGB1的AAV2YF3突变体定向修饰人MSC-exosome的表达率分别超过40%和60%。④相比天然状态,PD-L1和PD-L1-ITGB1定向修饰后MSC-exosome在体内对抗原特异性活化的OT-1细胞具有更好的增殖抑制效果;在体外亦能明显抑制活化T细胞的增殖,并诱导提高Treg的比例。 结论: MSC-exosome具有与MSC相似的免疫调节作用。经过PD-L1和PD-L1-ITGB1修饰后的MSC-exosome能够有效抑制活化T细胞的增殖,并且能够诱导提高Treg的比例。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu L, Shao WW, Li CW, et al. [The immunoregulatory functions of exosome derived from mesenchymal stem cells that are genetically modified by adeno-associated virus]. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 34384150. doi:10.3760/cma.j.issn.0253-2727.2021.06.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。